Literature DB >> 25579541

Esophageal suspension method in scavenging peripheral lymph nodes of the left recurrent laryngeal nerve in thoracic esophageal carcinoma through semi-prone-position thoracoscopy.

Wei Zheng, Yong Zhu, Chao-Hui Guo, Bin Zheng, Zi-Yang Han, Chun Chen1.   

Abstract

OBJECTIVE: Many Chinese doctors have performed microinvasive esophageal cancer resection in the semi-prone position. However, few reports have focused on high-quality methods of scavenging the peripheral lymph nodes (PLNs) of the left recurrent laryngeal nerve (RLN).
MATERIALS AND METHODS: Retrospective analysis was performed on 145 cases of microinvasive esophageal cancer resection in the semi-prone position. Among which, 75 cases underwent complete freeing of the thoracic esophagus and subsequent scavenging of the PLNs of the left RLN from April 2011 to April 2012 (Group A). In the other 70 cases, the incompletely freed upper thoracic esophagus was suspended, and the PLNs of the left RLN were scavenged from May 2012 to April 2013 (Group B).
RESULTS: The average number of scavenged PLNs of the left RLN in Groups A and B was 4.6±2.9 and 5.2±3.0 pieces, respectively (P=0.799). The total scavenged PLNs of the left RLN in Groups A and B were 344 and 357 pieces, respectively. Among which, the broken lymph nodes were 109 and 66 pieces, respectively (P<0.0001). The postoperative hoarseness rate in Groups A and B was respectively 12.0% and 2.8% (P=0.038).
CONCLUSIONS: Dissection of the left RLN can be easily performed after esophageal suspension, thus ensuring the quality of PLN scavenging.

Entities:  

Mesh:

Year:  2014        PMID: 25579541     DOI: 10.4103/0973-1482.144354

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  7 in total

1.  An original technique for lymph node dissection along the left recurrent laryngeal nerve after stripping the residual esophagus during video-assisted thorocoscopic surgery of esophagus.

Authors:  Hiroshi Makino; Hiroshi Yoshida; Hiroshi Maruyama; Tadashi Yokoyama; Atsushi Hirakata; Jyunji Ueda; Hideyuki Takada; Takeshi Matsutani; Tsutomu Nomura; Nobutoshi Hagiwara; Eiji Uchida
Journal:  J Vis Surg       Date:  2016-11-25

2.  Feasibility and outcomes of modified enhanced recovery after surgery for nursing management of aged patients undergoing esophagectomy.

Authors:  Wei Li; Bin Zheng; Shuliang Zhang; Hao Chen; Wei Zheng; Chun Chen
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Minimally invasive esophagectomy: a propensity score-matched analysis of semiprone versus prone position.

Authors:  Maarten F J Seesing; Lucas Goense; Jelle P Ruurda; Misha D P Luyer; Grard A P Nieuwenhuijzen; Richard van Hillegersberg
Journal:  Surg Endosc       Date:  2017-12-05       Impact factor: 4.584

4.  Robotic-assisted minimally invasive oesophagectomy for cancer: An initial experience.

Authors:  Chinnusamy Palanivelu; Sumanta Dey; Sandeep Sabnis; Raghavendra Gupta; Bharath Cumar; Saravana Kumar; Ramesh Natarajan; Parthasarathi Ramakrishnan
Journal:  J Minim Access Surg       Date:  2019 Jul-Sep       Impact factor: 1.407

5.  Novel technique for lymphadenectomy along left recurrent laryngeal nerve during thoracoscopic esophagectomy.

Authors:  Wen-Shu Chen; Li-Huan Zhu; Wu-Jin Li; Peng-Jie Tu; Jian-Yuan Huang; Pei-Lin You; Xiao-Jie Pan
Journal:  World J Gastroenterol       Date:  2020-03-28       Impact factor: 5.742

6.  How to distinguish thoracic and cervical lymph nodes during minimally invasive esophagectomy.

Authors:  Taidui Zeng; Maohui Chen; Bingqiang Cai; Wei Zheng; Chi Xu; Guobing Xu; Chun Chen; Bin Zheng
Journal:  Thorac Cancer       Date:  2022-07-18       Impact factor: 3.223

7.  High programmed death-ligand 1 expression is a poor prognostic indicator for esophageal squamous cell carcinoma and is correlated with two-field lymph node metastasis.

Authors:  Mingqiang Liang; Fengqiang Yu; Weidong Wu; Hao Chen; Bin Zheng; Wei Zheng; Yong Zhu; Chun Chen
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.